scholarly article | Q13442814 |
P356 | DOI | 10.1177/0272989X9701700203 |
P698 | PubMed publication ID | 9107608 |
P50 | author | Murray Krahn | Q41896189 |
P2093 | author name string | D A Redelmeier | |
G Naglie | |||
A S Detsky | |||
D Naimark | |||
P2860 | cites work | Meta-analysis in clinical research | Q29620885 |
Measurement of health state utilities for economic appraisal | Q33628526 | ||
Methodology for measuring health-state preferences--III: Population and context effects | Q38652675 | ||
Methodology for measuring health-state preferences--IV: Progress and a research agenda | Q38673857 | ||
Primer on medical decision analysis: Part 4--Analyzing the model and interpreting the results | Q41434879 | ||
Availability, wishful thinking, and physicians' diagnostic judgments for patients with suspected bacteremia | Q44941586 | ||
Clinical assessment of the probability of coronary artery disease: judgmental bias from personal knowledge | Q46555833 | ||
The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors | Q50126848 | ||
A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. | Q52713010 | ||
A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. | Q52713063 | ||
Primer on Medical Decision Analysis: Part 2—Building a Tree | Q57696070 | ||
Users' Guides to the Medical Literature | Q58040959 | ||
P433 | issue | 2 | |
P921 | main subject | decision analysis | Q5249226 |
P304 | page(s) | 136-141 | |
P577 | publication date | 1997-04-01 | |
P1433 | published in | Medical Decision Making | Q6806321 |
P1476 | title | Primer on medical decision analysis: Part 3--Estimating probabilities and utilities | |
P478 | volume | 17 |
Q35936893 | A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions. |
Q38824837 | A cost-effectiveness analysis of off-label atypical antipsychotic treatment in children and adolescents with ADHD who have failed stimulant therapy |
Q37459454 | A cost-utility analysis of amputation versus salvage for Gustilo type IIIB and IIIC open tibial fractures |
Q30634835 | A decision analysis of amputation versus reconstruction for severe open tibial fracture from the physician and patient perspectives |
Q34237662 | A decision analysis of the optimal initial approach to achalasia: laparoscopic Heller myotomy with partial fundoplication, thoracoscopic Heller myotomy, pneumatic dilatation, or botulinum toxin injection |
Q45809265 | A linear index for predicting joint health-states utilities from single health-states utilities |
Q38585100 | Acute Appendicitis in the Adult Population: Modelled Decision Analysis Supports a Conservative Approach |
Q57153443 | Adjuvant Versus Salvage Radiotherapy for Patients With Adverse Pathological Findings Following Radical Prostatectomy: A Decision Analysis |
Q34548875 | An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment |
Q34945083 | Analytic tools for public health decision making |
Q37060584 | Balloon angioplasty is preferred to surgery for aortic coarctation |
Q30844908 | Brain neoplasms: epidemiology, diagnosis, and prospects for cost-effective imaging |
Q35901636 | Can differences in breast cancer utilities explain disparities in breast cancer care? |
Q41876494 | Clinical decision analysis: Incorporating the evidence with patient preferences. |
Q74419882 | Clinical decisions: from art to science and back again |
Q35889164 | Clinical impact of treatment timing for chronic hepatitis C infection: a decision model |
Q99556704 | Comparison of risk-of-bias assessment approaches for selection of studies reporting prevalence for economic analyses |
Q73741952 | Computer-assisted decision analysis in orthopedics: resurfacing the patella in total knee arthroplasty as an example |
Q46312165 | Cost-Effectiveness Analysis of Latent versus Active Labor Hospital Admission for Medically Low-Risk, Term Women. |
Q43721563 | Cost-benefit analysis of screening strategies by human immunodeficiency virus in French blood donors |
Q41216681 | Cost-effective analysis of topical chlorhexidine in hematologic patients at risk for oral mucositis |
Q48684821 | Cost-effectiveness analysis of two caries prevention methods in the first permanent molar in children |
Q99550133 | Cost-effectiveness analysis of using the TBX6-associated congenital scoliosis risk score (TACScore) in genetic diagnosis of congenital scoliosis |
Q38226736 | Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer |
Q31132856 | Cost-effectiveness of testing for human immunodeficiency virus and hepatitis C virus among blood transfusion recipients |
Q82461835 | Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina |
Q34133994 | Decision analysis and its application in clinical medicine |
Q50133467 | Decision analysis in evidence-based decision making |
Q34274202 | Decision analysis in plastic surgery: a primer |
Q44015434 | Decision analysis with cumulative prospect theory |
Q35799904 | Decision analysis, economic evaluation, and newborn screening: challenges and opportunities |
Q33833347 | Determining utility values related to malaria and malaria chemoprophylaxis |
Q40101200 | Early Versus Delayed Surgical Decompression of Spinal Cord after Traumatic Cervical Spinal Cord Injury: A Cost-Utility Analysis |
Q37501149 | Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty |
Q28364493 | Effects of patients' preferences on the treatment of atrial fibrillation: observational study of patient-based decision analysis |
Q35112353 | Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact |
Q35551764 | Fundamental principles of conducting a surgery economic analysis study |
Q44612807 | Guidelines for verbal presentations of medical decision analyses |
Q44782868 | Harnessing experience: exploring the gap between evidence-based medicine and clinical practice |
Q35103628 | Health care economic analyses and value-based medicine |
Q34089803 | Health economics of contraception |
Q84916178 | Identification of the optimal pathway to reach an accurate diagnosis in the absence of an early detection strategy for ovarian cancer |
Q45279315 | Impact of antidepressants on the risk of suicide in patients with depression in real-life conditions: a decision analysis model |
Q39908828 | Initial development of the Temporary Utilities Index: a multiattribute system for classifying the functional health impact of diagnostic testing |
Q46338637 | Management of biliary tract disease during pregnancy: a decision analysis |
Q47329063 | Management of the second episode of spontaneous pneumothorax: a decision analysis |
Q57244356 | Modeling methods for facilitating decisions in pharmaceutical policy and population therapeutics |
Q79467681 | Operative strategies for diverticular peritonitis: a decision analysis between primary resection and anastomosis versus Hartmann's procedures |
Q35805877 | Optimal management of colorectal liver metastases in older patients: a decision analysis |
Q35037324 | Paying for prevention standardizing the measurement of the value of health care interventions |
Q51899089 | Predicting utility ratings for joint health States from single health States in prostate cancer: empirical testing of 3 alternative theories. |
Q38839558 | Predictors of 6-month health utility outcomes in survivors of acute respiratory distress syndrome |
Q28191848 | Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making |
Q34732064 | Preferences of husbands and wives for outcomes of prostate cancer screening and treatment |
Q51094318 | Pretherapy dental decisions in patients with head and neck cancer. A proposed model for dental decision support. |
Q45032581 | Prevalence of chronic kidney disease risk factors among low birth weight adolescents |
Q57696070 | Primer on Medical Decision Analysis: Part 2—Building a Tree |
Q41434871 | Primer on medical decision analysis: Part 1--Getting started. |
Q41434879 | Primer on medical decision analysis: Part 4--Analyzing the model and interpreting the results |
Q33919309 | Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysis |
Q35606459 | Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas |
Q52926201 | QUOROM and the search for an updated 'clinical method' in the era of evidence-based medicine. |
Q35589372 | Quality of life and systemic comorbidities in patients with ophthalmic disease |
Q44072630 | Response to "Limitations of the study 'Cost-effectiveness of tick-borne encephalitis vaccination in Slovenian adults"'. |
Q39396013 | Safety, efficacy and costs of pharmacotherapy for functional gastrointestinal disorders: the case of alosetron and its implications |
Q48436377 | Should risky treatments be reserved for secondary prevention? Theoretical considerations regarding risk-benefit tradeoffs. |
Q40699343 | Surgical Management of the Elderly With Traumatic Cervical Spinal Cord Injury: A Cost-Utility Analysis |
Q79691418 | Surgical resection versus palliative chemoradiotherapy for the management of pancreatic cancer with local venous invasion: a decision analysis |
Q24792533 | The DiAMOND trial protocol: a randomised controlled trial of two decision aids for mode of delivery among women with a previous caesarean section [ISRCTN84367722] |
Q34608270 | The clinical decision analysis using decision tree |
Q41892166 | The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost-utility analysis |
Q36295307 | The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers |
Q36925939 | The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis |
Q44948886 | The half-cycle correction explained: two alternative pedagogical approaches |
Q36537695 | The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes |
Q37333837 | The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis |
Q53170146 | The surgical treatment of cubital tunnel syndrome: a decision analysis. |
Q51189533 | Treatment of ulnar neuropathy at the elbow: cost-utility analysis. |
Q36442047 | Trial of labor versus elective repeat cesarean section for the women with a previous cesarean section: a decision analysis |
Q37137827 | Variation in treatment preferences and care goals among older patients with diabetes and their physicians |
Q42580388 | What is a clinical decision analysis study? |